Close
Digital Health & Ai Innovation summit 2026
APE 2026

SNUH reaffirms efficacy of Lunit’s AI system in detecting lung cancer

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Konica Minolta and deepc AI Partnership...

Konica Minolta Healthcare Americas and deepc have formed a...

Medtronic Wins FDA Clearance for MiniMed...

Medtronic has received U.S. Food and Drug Administration (FDA)...

Novartis Plans its Fourth US Radioligand...

Novartis, which is a world-leading innovative medicines company, has...

Researchers at Seoul National University Hospital (SNUH) have confirmed once again the efficacy of an artificial intelligence-based X-ray system, co-developed by the hospital and Lunit, in detecting lung cancer.

More than five million people receive health screening in Korea every year, with many receiving chest X-rays as part of the health screening. This has led to a heavy workload for radiologists and increased risk of reading errors.

As the researchers reaffirmed the AI-based system’s efficacy, the team expects to relieve some of the heavy workloads in the field.

To confirm its efficacy, the team, led by Professors Park Chang-min, Lee Jong-hyuk, Sun Hye-young at the hospital, analyzed the chest X-ray data of 50,070 patients who received a health screening from 2012 to 2018.

The team’s total images amounted to 100,576 copies, while 98 pictures were of actual lung cancer patients. However, the team excluded 51 images, which were hard to be diagnosed as lung cancer by using only X-ray images.

As a result, the AI system showed the accuracy and sensitivity of 97 and 83 percent, respectively. In the cases of highly visible lung cancer images, the system showed 100 percent sensitivity.

“This study is significant, as we tested the machine in an actual clinical setting for healthy adults,” the team said. “While previous tests confirmed the efficacy of an AI diagnostic system, there had been no studies that applied the device to healthy adults with low disease rates until then.”

Even though the lung cancer prevalence among the examined images was 0.1 percent, which was quite low, the test still managed to show high sensitivity in the real world, the team added.

Professor Park said, “The study has confirmed that the AI system is useful for finding lung cancer in a large-scale medical examination.”

The team will continue research and development so that AI can be of practical help to both patients and ordinary people, Park added.

Latest stories

Related stories

Konica Minolta and deepc AI Partnership Expands Exa Platform

Konica Minolta Healthcare Americas and deepc have formed a...

Medtronic Wins FDA Clearance for MiniMed Go Smart MDI System

Medtronic has received U.S. Food and Drug Administration (FDA)...

Novartis Plans its Fourth US Radioligand Therapy Facility

Novartis, which is a world-leading innovative medicines company, has...

Tempus-NYU Langone Collaboration Advances Precision Oncology

Tempus and NYU Langone Health have signed a multi-year...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »